Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Phase I, Dose-Escalation Study of Iodine-131 Anti-B1 Antibody for Patients with Previously Treated Non Hodgkin’s Lymphoma With More Than 25% Bone Marrow Involvement
tositumomab
BEX104512
NCT00992758
Lymphoma, Non-Hodgkin
Phase 1
 
July 2015

Powered by ideaPoint, Inc.